Digital Twins in Healthcare Companies

The digital twins in healthcare market is projected to reach USD 101.19 billion by 2031 from USD 7.47 billion in 2026, at a CAGR of 68.4% during the forecast period. The growth is driven by increasing adoption across pharmaceutical, biotechnology, and clinical research ecosystems. Digital twins, virtual replicas of patients or biological systems, are being used to simulate disease progression, predict treatment outcomes and optimize clinical trial design. 

According to publicly available industry and scientific sources, pharmaceutical companies are increasingly integrating digital twin models into clinical development just to enhance efficiency and decision-making. As the pharmaceutical industry gets more data-driven and simulation-oriented, digital twins are enabling “virtual clinical trials,” where patient outcomes can be modeled before real-world execution. This reduces uncertainty within trial design and improves success rates. For instance, digital twins can act as predictive models within randomized trials, helping reduce variability and improve statistical confidence without replacing human participants. Adoption is also accelerating due to regulatory and technological advancements. Frameworks such as the US FDA Modernization Act 2.0 support the use of computational models to reduce reliance on traditional testing methods. And digital twin platforms are being deployed across hundreds of hospitals and applied to hundreds of thousands of patient datasets, highlighting real-world scalability. Overall, the growing use of simulation-based clinical development, reduced trial sizes (by up to 30-50%), and increasing reliance on virtual patient models are driving demand for digital twin platforms, signaling a structural shift toward predictive, data-centric healthcare innovation.

To know about the assumptions considered for the study download the pdf brochure

Prominent players in the digital twins in healthcare market include Microsoft Corporation (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Amazon Web Services, Inc. (US), Dassault Systèmes (France), GE Healthcare (US), IBM (US), NVIDIA Corporation (US), Oracle Corporation (US), PTC (US), SAP (Germany), Atos SE (France), ANSYS, Inc. (US), Faststream Technologies (US), Rescale, Inc. (US), Twin Health (US), NUREA (France), Predictiv (US), Verto (Canada), Qbio (US), Virtonomy GmbH (Germany), Unlearn.ai, Inc.  (US), ThoughtWire (Canada), Sim and Cure (France), and PrediSurge (France).

Microsoft Corporation (US)

Microsoft Corporation is one of the premier suppliers of digital twins solutions and provides an extensive range of cloud platforms, developer tools and healthcare data analytics solutions. Microsoft continues to innovate heavily with a keen interest in enhancing its competencies in the areas of cloud computing, artificial intelligence and new generation digital platforms. As of June 2025, the company employed approximately 228,000 people globally, of which around 80,000 employees were engaged in product research and development activities. The company's R&D expenditure reached USD 32.5 billion in FY2025, reflecting a significant increase driven by continued investments in cloud infrastructure and AI engineering. Microsoft markets its solutions throughout the world using a strong global footprint. The company strives to build on its competencies through strategic partnerships, ecosystem building and continued investment in cutting-edge technologies, making it a dominant player in the digital twins in healthcare market.

Siemens Healthineers AG (Germany)

Siemens Healthineers is one of the most influential companies in the market for digital twins in healthcare. First, it has the advantage of being a pioneer in the market, enabling it to establish itself amid increased competition. This strength has helped the company grow its market share quickly through product innovation, such as the Digital Twin of the Heart. Second, the company has a higher margin of profitability than its rivals. While the market conditions affect profitability, Siemens Healthineers maintains high profit margins, which signify excellent business practices. The third strength of the company is its global presence, utilizing dealers and associates to provide quality services and manage competition efficiently.

Koninklijke Philips N.V.

Koninklijke Philips N.V. (the Netherlands) is one of the leading companies operating in the digital twins in healthcare sector, with the use of its innovations in the field of imaging, monitoring, and informatics to create digital models of patients and health care systems. The company uses information collected through imaging, connected care, and electronic medical records technologies to provide patient-specific digital representations, which help in precision diagnostics and planning of the treatment. The use of the Philips HealthSuite platform allows the company to aggregate data and conduct analytics, creating the basis for further development of digital twins technology. Philips has been actively working on digital twin concepts in such medical fields as cardiology, with the application of virtual models to simulate heart diseases and their treatment. These tools will allow physicians to analyze various treatment options and make decisions that will bring better clinical results. At the same time, the company cooperates with healthcare organizations and academic institutes to develop innovative predictive care models based on simulations. The integration of ecosystems for data-driven and continuous patient monitoring allows moving from a reactive to a proactive healthcare model.

Market Ranking

The ranking of companies in the digital twins in healthcare market has been determined through a market share analysis, conducted after thorough secondary research and validated by primary respondents. This ranking considers parameters such as revenue generated from digital twins, product portfolio breadth and depth, innovation, and launches. Based on this analysis, the top players leading the market are Siemens Healthineers AG (Germany), Dassault Systèmes (France), Microsoft Corporation (US), and Koninklijke Philips N.V. (Netherlands). The companies leverage their strong R&D, diversified product portfolio, and broad geographic presence, and continuous innovation in the digital twins in healthcare market. Microsoft Corporation leads the industry in terms of superior digital twins, while Siemens Healthineers enjoys its position due to its leadership in health solutions and services. In Feb 2026, Dassault Systemes and NVIDIA announced a multi-year strategic partnership to deliver an industrial AI platform that integrates virtual twin technology and NVIDIA's AI infrastructure to create "industry world models" used for simulation and decision-making at scale. And in 2023, Siemens Healthineers collaborated with Harapan Kita National Cardiovascular Center Hospital centers on the “Digital Twin” concept. This innovative approach seeks to develop patient replicas for early detection, personalized treatment planning, risk prediction, and scenario simulation.

Related Reports:

Digital Twins in Healthcare Market By Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]